Are variations of glycated hemoglobin given by the freestyle device accurate? by Senterre, Yseult et al.
Y. Senterre2, K. Fombellida2, E. Cavalier1, N. Paquot2, P. Delanaye3
1 Clinical Chemistry, CHU Sart Tilman, University of Liège , 
2 Metabolic Diseases, CHU Sart Tilman,  University of Liège, 
3 Nephrology, CHU Sart Tilman, University of Liège
METHODS
Patients from our University hospital with the
following criteria were considered: type 1
diabetes with FSL and two values of A1C within
an interval of 80 to 100 days, values obtained
from FSL (Abbot Diabetes Care) on one part and
the laboratory (HPLC, HA8180, Menarini) on the
other part.
The values should be obtained within the same
period (±8 days). According to biological
variation of A1C measurement, a change in A1C
concentration of minimum ±6% was considered
as clinically significant. Accordingly, the patients
were classified with the two techniques as
stable, “improving” (value decreased) or
“worsening” (value increased).
CONCLUSION
In this study, we showed that variations of A1C are correctly assessed by eA1C in
two-third of the patients. In the remaining third, discrepancies are observed
between stable and others, but “improving” patients are never classified as
“worsening” (or the inverse).
ARE VARIATIONS OF GLYCATED HEMOGLOBIN 
GIVEN BY THE FREESTYLE DEVICE ACCURATE?
BACKGROUND-AIM
Continuous glucose monitoring (CGM) by
interstitial glucose fluid monitoring is a major
recent improvement in the global care of
diabetic patients. The FreeStyle Libre (FSL)
allows CGM, but can also provide an estimated
glycated hemoglobin (eA1C) based on serial
interstitial glycaemia. Several studies showed a
good correlation between eA1C and measured
glycated hemoglobin (A1C) in cross-sectional
designs.
In the current study, we studied the ability of the
FSL to correctly estimate such variations of A1C.
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